Indications
Colics such as intestinal, biliary and ureteric
Spasmodic dysmenorrhea
          
Contraindications
Drogex-M (Drotaverine & Mefenemic Acid) Tablets should not be used in patients who have previously exhibited hypersensitivity to its ingredients, or another NSAID. It is contraindicated in presence of active ulceration or chronic inflammation of either the upper or lower gastrointestinal tract, preexisting renal disease due to mefenamic acid.
 
Drogex-M (Drotaverine & Mefenemic Acid) Tablet is contraindicated in pregnancy especially in the third trimester; it is strictly not advocated for small children less than 6 months, and during lactation.

Precaution & Warnings
Drogex-M (Drotaverine & Mefenemic Acid) Tablet should be administered during the first 6 months of pregnancy only if strictly required.
          
Mefenamic acid (in Drogex-M) can cause reduced renal blood flow in presence of impaired renal function, heart failure, liver dysfunction, in those taking concomitant diuretics, and in the elderly.
          
It is unknown whether drotaverine is excreted in human breast milk, and hence the use of Drogex-M during lactation must be if only strictly required.
          
Mefenamic acid (in Drogex-M) should be co-administered with caution along with oral anticoagulants.
          
Dosage & Administration
ADULTS: 1 Drogex-M Tab tid, or as prescribed.
ELDERLY CHILDREN: ½-1 Drogex-M Tab tid, or as prescribed.
Therapy should not exceed one week.
          
Presentations
Drogex-M Tablets: Blisters of 10s.